Back to Search
Start Over
BIOCON MEETS CLINICAL TRIAL MILESTONE FOR PSORIASIS DRUG (by meeting the primary and secondary goals of clinical trials for 'itolizumab' conducted on 200 patients over 52 weeks)
- Source :
- India Business Insight. January 11, 2012
- Publication Year :
- 2012
-
Abstract
- Biocon of Bangalore is making efforts to bring out its affordable drug 'itolizumab', which is used for the treatment of psoriasis. It has met the primary and secondary goals of [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- India Business Insight
- Publication Type :
- Periodical
- Accession number :
- edsgcl.277179064